Amino terminus-blocked peptide boronate compounds of Formulas I and II are useful for inhibiting Fibroblast Activation Protein (FAP) and other proteases, and for treating disorders mediated by FAP. Methods of using the amino terminus blocked peptide boronate compounds, and stereoisomers, tautomers, solvates and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
I和II式的
氨基端阻断肽
硼酸化合物可用于抑制成纤维细胞活化蛋白(FAP)和其他
蛋白酶,并用于治疗由FAP介导的疾病。本文披露了使用
氨基端阻断肽
硼酸化合物及其立体异构体、互变异构体、溶剂化物和药学上可接受的盐,在哺乳动物细胞中进行体外、体内和原位诊断、预防或治疗此类疾病或相关病理条件的方法。